Table 4 Stepwise linear regression of reductions in MADRS scores on day 13 and level of cytokine at baseline.

From: Alterations of multiple peripheral inflammatory cytokine levels after repeated ketamine infusions in major depressive disorder

Dependent variable

Independent variable

B

S.E.

β

t

p

95% CI

Reduction in MADRS on day 13

ITAC

−12.557

5.95

−0.296

−2.110

0.040

−24.508 to −0.606

  1. ITAC interferon-inducible T cell alpha chemoattractant, MADRS Montgomery–Asberg Depression Rating Scale, S.E. standard error, CI confidence interval.
  2. There were two blocks of independent variables in this linear regression model, the first block included age, gender, BMI, dose of antidepressant, and combined use of mood stabilizer/benzodiazepine/antipsychotic, and the second block included cytokines that were significantly correlated with reduction in MADRS on day 13.